RVLLF Stock News 0.0206 05/08/2014 08:30:59 Revolver Resources

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Revolver Resources (RVLLF) 0.0206 $RVLLF

Revolver Resources Announces Re-Appointment of President and CEO
Marketwire - Fri Mar 07, 3:34PM CST
Revolver Resources Inc. ("Revolver" (the "Company" (TSX VENTURE: RZ) is pleased to announce the re-appointment of Mr. Robert Birmingham as President and CEO of the Company. Mr. Birmingham was the previous President and CEO of Revolver Resources Inc. and has been instrumental in project definition, project evaluation and raising capital with Revolver since joining the Company in February 2012.

Pistol Bay's JV Partner Revolver Resources Reports Assay Results from Summit B
Marketwire - Thu Feb 20, 1:15PM CST
Pistol Bay Mining Inc. (TSX VENTURE: PST) ("the Company" reports that Revolver Resources Inc. (Revolver), joint venture partner on the Summit B property, announces initial assay results. The 1,394 hectare (3,446 acre) Summit B property is located in the Iskut area of northwestern British Columbia, Canada, and is contiguous with Colorado Resources Ltd.'s ("Colorado" North Rok copper-gold property (the "North Rok Property". Revolver has the option to earn a 60-per-cent interest in the property by completing $2.5-million in exploration expenditures on the property, making $500,000 in cash payments to Pistol Bay and issuing Pistol Bay four million common shares over the next three years.

Revolver Resources Unveils First Assay Results of Its Summit B Drilling Campaign
Marketwire - Thu Feb 20, 8:31AM CST
Revolver Resources Inc. ("Revolver" (TSX VENTURE: RZ) is releasing the assay results of the first two of its three diamond drill holes program on its Summit B property. The 1,394 hectare (3,446 acre) Summit B property is located in the Iskut area of northwestern British Columbia, Canada, and is contiguous with Colorado Resources Ltd.'s ("Colorado" North Rok copper-gold property (the "North Rok Property".

Revolver Closes Non-Brokered Private Placement
Marketwire - Wed Feb 12, 4:26PM CST
Revolver Resources Inc. (the "Company" (TSX VENTURE: RZ) is pleased to announce that it has closed the first-tranche (the "First Tranche" of its non-brokered private placement (the "Private Placement", previously announced on January 28, 2014, for gross proceeds of $367,996.86.

Revolver Resources Completes Drill Program on Summit B
Marketwire - Wed Feb 05, 11:00AM CST
Revolver Resources Inc. (TSX VENTURE: RZ) ("Revolver" is pleased to announce it has completed its 1010 m drill program distributed in three DDH on its Summit B project located in NW British Columbia. The exploratory diamond drill program was designed to test the anomaly previously identified through its IP survey. The 3D IP inversion model reveals a strong 2.0 km long-500 m wide, 35 mV/V, NW-oriented ovoid chargeability anomaly accompanied by low resistivity and magnetic signatures.

Revolver Resources Announces Appointment of New President and CEO
Marketwire - Thu Jan 30, 1:17PM CST
Revolver Resources Inc. ("Revolver" (TSX VENTURE: RZ) is pleased to announce the appointment of Michel Boily, P. Geo. as President and Chief Executive Officer of the Company. Robert Birmingham has resigned as President and Chief Executive Officer and will remain on Revolver as a director of the Company.

Revolver Resources Announces Financing, Provides Update
Marketwire - Tue Jan 28, 12:51PM CST
Revolver Resources Inc. ("Revolver" (TSX VENTURE: RZ) wishes to announce that, subject to regulatory approval, it has arranged a private placement of up to 8,000,000 units at price of $0.06 per unit for gross proceeds of $480,000. Each unit will consist of one common share and one transferable share purchase warrant. Each warrant shall be exercisable into one common share for a period of one year at a price of $0.12 per share. Proceeds of the placement will be used on the current drill program on the Summit B project and for general working capital. The Company will also pay a finder's fees in accordance with the policies of the TSX Venture Exchange.

Revolver Resources Inc. Announces Grant of Stock Options
Marketwire - Tue Jan 14, 3:16PM CST
Revolver Resources Inc. (the "Company" (TSX VENTURE: RZ) announces that it has granted stock options under its stock option plan to directors, officers and consultants of the Company for the purchase of up to 1,000,000 common shares at a price of $0.05 per share for a period of 5 years. The announced stock options are subject to the acceptance of the TSX Venture Exchange.

Revolver Resources Completes Initial Drill Hole
Marketwire - Mon Jan 13, 3:01PM CST
Revolver Resources Inc. (TSX VENTURE: RZ) ("Revolver" is pleased to announce that it has completed the first 400 m drill hole of its planned 1000 m three DDH program on the Summit B property located in NW British Columbia (see news release December 9th, 2013). The first drill hole is being split and will be sent to be assayed with the results expected in the next weeks. Revolver anticipates the completion of the next two drill holes within the next three weeks.

Revolver Resources to Resume Drill Program on Summit B
Marketwire - Tue Jan 07, 11:48AM CST
Revolver Resources Inc. (TSX VENTURE: RZ) ("Revolver" is pleased to announce that it has resumed its 1000 metre drill program on its Summit B property, which was initiated in December 2013. The drill program is aimed to test the 2km long and 500 metre wide anomaly previously identified through its 3D IP survey.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading